ADRENAL GLAND NEOPLASMS
Clinical trials for ADRENAL GLAND NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ADRENAL GLAND NEOPLASMS trials appear
Sign up with your email to follow new studies for ADRENAL GLAND NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: ADRENAL GLAND NEOPLASMS
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New hope for liver cancers: targeted chemo plus immune booster shows promise
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal cancer, bile duct cancer, or adrenal cancer that is mainly in the liver w…
Matched conditions: ADRENAL GLAND NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC